Dudediligence.

Vertex Pharmaceuticals Incorporated

VRTXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.77BSep ’24$2.91BDec ’24$2.77BMar ’25$2.96BJun ’25$3.08BSep ’25$3.19BDec ’25$2.99BMar ’26$3.33BJun ’26
Net income, by quarter
$1.05BSep ’24$913.0MDec ’24$646.3MMar ’25$1.03BJun ’25$1.08BSep ’25$1.19BDec ’25$1.03BMar ’26$1.10BJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$7.57B$8.93B$9.87B$11.02B$12.00B
Gross profit$6.67B$7.85B$8.61B$9.49B$10.35B
Operating income$2.78B$4.31B$3.83B−$232.9M$4.17B
Net income$2.34B$3.32B$3.62B−$535.6M$3.95B
Operating cash flow$2.64B$4.13B$3.54B−$492.6M$3.63B
Free cash flow$2.41B$3.93B$3.34B−$790.3M$3.19B
Cash$6.79B$10.50B$10.37B$4.57B$5.08B
Shares outstanding254.5M257.0M257.7M256.9M254.0M